Clinical Trials Study
Copyright ©The Author(s) 2023.
World J Diabetes. Mar 15, 2023; 14(3): 279-289
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.279
Figure 2
Figure 2 Scatter plot the correlation between natural logarithm of urinary albumin-to-creatinine ratio and postprandial glucagon-like peptide 1 levels. A: Scatter plot for the correlations between 30 min glucagon-like peptide 1 (GLP-1) levels and the urinary albumin-creatinine ratio (UACR) in all type 2 diabetes mellitus (T2DM) patients; B: Scatter plot for the correlations between 120 min GLP-1 levels and the UACR in all T2DM patients; C: Scatter plot for the correlations between area under the curve for GLP-1 and the UACR in all T2DM patients. GLP-1: Glucagon-like peptide 1; UACR: Urinary albumin-creatinine ratio; AUCGLP-1: Area under the curve for active glucagon-like peptide 1; LnUACR: Natural logarithm of urinary albumin-to-creatinine ratio.